Renaissance Technologies
BIOC

Renaissance Technologies’s Biocept, Inc. BIOC Stock Holding History

Renaissance Technologies’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,458
Closed -$66K – 4425
2023
Q1 		$66K Buy
6,458
+1,048
+19% +$15.2K ﹤0.01% 3599
2022
Q4 		$86K Sell
5,410
-203
-4% -$4.48K ﹤0.01% 3669
2022
Q3 		$155K Sell
5,613
-237
-4% -$7.01K ﹤0.01% 3465
2022
Q2 		$165K Buy
5,850
+1,970
+51% +$89.7K ﹤0.01% 3721
2022
Q1 		$270K Buy
3,880
+827
+27% +$65K ﹤0.01% 3517
2021
Q4 		$332K Buy
3,053
+1,360
+80% +$157K ﹤0.01% 3297
2021
Q3 		$204K Buy
+1,693
New +$198K ﹤0.01% 3200
2020
Q4 		– Sell
-362
Closed -$48K – 3818
2020
Q3 		$48K Sell
362
-12,293
-97% -$2.48M ﹤0.01% 3281
2020
Q2 		$2.7M Buy
12,655
+6,574
+108% +$943K ﹤0.01% 2001
2020
Q1 		$483K Buy
6,081
+4,555
+298% +$466K ﹤0.01% 2773
2019
Q4 		$131K Buy
+1,526
New +$263K ﹤0.01% 3267
2019
Q1 		– Sell
-147
Closed -$38K – 3771
2018
Q4 		$38K Buy
+147
New +$73.8K ﹤0.01% 3302

Other funds holding BIOC

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies's BIOC Position: Q2 2023 in Review

Renaissance Technologies sold out of Biocept, Inc. (BIOC) in Q2 2023, closing a stake of 6,458 shares — an estimated $66K sold.

Renaissance Technologies first reported a position in BIOC in Q4 2018 and held it in 12 quarters. The position peaked at $2.7M in Q2 2020. 11 funds tracked by Wall St. Rank hold BIOC as of Q2 2023.

  • Renaissance Technologies reported no remaining Biocept, Inc. position as of Q2 2023 after selling out during the quarter.
  • Renaissance Technologies sold 6,458 Biocept, Inc. shares in Q2 2023, an estimated $66K.
  • Renaissance Technologies first reported a position in Biocept, Inc. in Q4 2018 and held it in 12 quarters.
  • Renaissance Technologies's Biocept, Inc. position peaked at $2.7M in Q2 2020.
  • 11 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.